Colorectal cancer, benign colon disease C18 C20 K57 D12
Conditions
Interventions
Group 1: On the day of the reconnaissance, the blood sampling with CRP, leukocytes, PCT, lactate and calprotectin. The next blood samples (CRP, leukocytes, PCT, lactate and Calprotectin) are performed
Sponsors
Krankenhaus Agatharied
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Potential study participants are all patients who undergo a colon / rectum resection at the Agatharied GmbH hospital, who are> 18 years of age and who have a written declaration of consent.
Exclusion criteria
Exclusion criteria: Patients under <18 years of age, patients with inflammatory bowel disease, emergency patients, and patients who do not consent to the study. Since calprotectin is also increased in other chronic infections and autoimmune diseases, such as rheumatoid arthritis, patients with chronic inflammation are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| How does the calprotectin level in the serum behave pre- and post-operatively after a colon / rectum resection? | — |
Secondary
| Measure | Time frame |
|---|---|
| Is there a change in the postoperative calprotectin serum level similar to that of leukocytes, PCT, lactate and CRP? Is there an increase in the calprotectin level with the onset of clinical symptoms, e.g. fever, pain, discharge of pus in postoperative infections, abscesses or anastomotic leakage? Does the calprotectin level change pre- and postoperatively due to the presence or removal of neoplasms compared to bowel resections without neoplasms? | — |
Countries
Germany
Contacts
Public ContactThomas von Ahnen
Krankenhaus Agatharied
Outcome results
None listed